InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by TUMOLO ANNETTE, Chairman & CEO. Officer active across 4 companies, notably Bio-Rad Laboratories, INC.. In total, 12 filings have been published. Split: 0 buy · 2 sells. Total volume traded: €809k. History available since 26 August 2021. The latest transaction was filed on 6 July 2023 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations12 total
46,752 shares0Common StockSEC:0000950170-24-053135:0
74,611 shares0Common StockSEC:0001209191-22-043010:0
613 shares@ US$333.3415.3% of flowBio-Rad A Common StockSEC:0001062993-21-010826:0
613 shares@ US$333.3415.3% of flowBio-Rad A Common StockSEC:0001062993-21-010826
600 shares0Bio-Rad A Common StockSEC:0001062993-21-008416:0
600 shares0Bio-Rad A Common StockSEC:0001062993-21-008416
557 shares0Bio-Rad A Common StockSEC:0001062993-21-008352:0
557 shares0Bio-Rad A Common StockSEC:0001062993-21-008352
433 shares0Bio-Rad A Common StockSEC:0001062993-21-008254:0
433 shares0Bio-Rad A Common StockSEC:0001062993-21-008254
600 shares@ US$792.5834.7% of flowBio-Rad A Common StockSEC:0001062993-21-007992:0
600 shares@ US$792.5834.7% of flowBio-Rad A Common StockSEC:0001062993-21-007992
12 of 12 declarations
About TUMOLO ANNETTE
Annette Tumolo is the President and CEO of Bio-Rad Laboratories, Inc. She oversees the company's operations and is responsible for growth strategy. Her experience in the life sciences sector is an asset for innovation and product development.
